RXMD OTCQB : Record Sales! Uplisted! Small Preserved SS! Audited! 14 State Licences!
Share Structure
Fully preserved OS: RXMD has basically the same OS number as compared to 2 years ago:
see ---
http://www.otcmarkets.com/stock/RXMD/profile
versus historic ---
https://web.archive.org/web/20151229173335/ht...MD/profile
Outstanding Shares a/o Jan 22, 2018 = 360,996,132 (Authorized Shares 500,000,000)
Outstanding Shares a/o Dec 09, 2015 = 352,043,045 (Authorized Shares 500,000,000)
Current market cap
of just 10 M is ~10-fold undervalued compared to hundreds of listed companies in this sector
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio* (up to 10x)...so for an estimated 25M revs in 2018 the RXMD pps fair market value, not even taking its constant market expansion into account, should be 30 cents (that is a conservative evaluation*)
14 state licenses. Expansion to 50 states
will follow within few years meaning revenue and profit multiplication!
https://ih.advfn.com/p.php?pid=nmona&article=76101390
http://finance.yahoo.com/news/progressive-car...26653.html
Now Licences pending in 3 new states : Utah, Arizona, and Rhode Island https://ih.advfn.com/p.php?pid=nmona&article=76101390
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
https://ih.advfn.com/p.php?pid=nmona&article=76552057
MIAMI, January 25, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital presence and technology solutions of the company and all subsidiaries.
Progressive Care engages Mass Ventures Corp to initiate a digital marketing campaign for both Progressive Care and PharmCo, LLC. The principle of Mass Ventures will be located on-site to provide real-time updates as needed. The campaign consists of many features including, but not limited to, website upgrades, enhanced and updated content, blog posting, social media development, press release distribution, search engine optimization, etc. Mass Ventures is also in the process of developing the Company’s e-commerce platform which will be capable of accepting all payment methods including cryptocurrencies such as Bitcoin. These measures are taken to coincide with the overall technological development of the company to improve the efficacy and exposure of the Company’s public information and virtual interaction with its shareholders and customers.
“The Mass Ventures Corp team has worked with us for over 5 years,” stated S. Parikh Mars, CEO. “We are excited to bring them on-site and begin a transformation of our online presence, as well as creating technology solutions that will modernize all areas of our enterprise. We believe that efforts in this area will make a difference in how we set ourselves apart as a company of the future. This will change how our shareholders and customers perceive and interact with us. Already, we are seeing the impact this project has had on our customer engagement and market awareness.”
“Progressive Care and PharmCo, LLC are ripe for exponential growth and success.” says Marcello Jaspan, owner and operator at MVC . “We are thrilled about the opportunity to serve such an amazing group and to work closely to create engagement and social buzz. On the technical side, we have infinite possibilities for expansion. We started with the launch of Tele-Pharmco, and we will soon have many Apps for customers and internal logistics alike. We will have goodies for everyone coming real soon, all aimed at making everyone’s lives easier and more enjoyable.”
Progressive Care Continues to Break Records with Over $20 Million in Sales
http://www.otcmarkets.com/stock/RXMD/news/Pro...50&b=y
MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.
PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.
The company has been successful in breaking records in 2017. The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”
S. Parikh Mars, CEO of Progressive Care Inc., Provides Progress Report and Outlook for Investors in New Audio Interview at SmallCapVoice.com
www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y
AUSTIN, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (The “Company”) (OTCQB:RXMD), today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-4-18-smallca...e-inc-rxmd.
S. Parikh Mars, CEO, called in to SmallCapVoice.com to discuss the business model and markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017. A major corporate milestone was also achieved in December as the Company was listed on a higher exchange, the OTC QB.
In the interview, Ms. Mars stated, “As experts in the pharmacy space, we market ourselves primarily to healthcare providers who are looking for pharmacies who they can recommend to their patients knowing that their patients will be well taken care of. We understand that the leading cause of ER visits and readmissions stems from a failure to adhere to a medication regiment and that affects healthcare costs and bottom lines across the healthcare system. By managing this risk, we deliver approved health outcomes to patient and lower health care costs to providers and insurance companies. This has allowed us to develop a solid reputation as a five-star pharmacy which has been a primary driver of increased sales and growth.”
For the video version of this interview, please visit https://youtu.be/oaylHtfuMgc.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-d...ewsletter/.
Progressive Care Announces Uplist to OTCQB
http://www.otcmarkets.com/stock/RXMD/news/Pro...41&b=y
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces OTC Markets approval for uplist to OTCQB effective December 5, 2017.
As of Tuesday, December 5 2017, Progressive Care will trade on OTCQB Venture Market for early stage and developing U.S. and international companies. The Company received approval for the change in listing tier after supplying OTC Markets with all mandatory documents and information, adding independent board members, adding a majority independent audit committee, and providing audited financial statements for 2016. Investors can still find Real-Time quotes and market information for the Company on www.otcmarkets.com (OTCQB:RXMD).
“We have been preparing for this moment since the requirements for OTCQB were announced earlier this year,” stated S. Parikh Mars, CEO. “We continue to take pride in delivering current and complete information to the public and we believe that the change in listing tier will bring our company to a fresh audience and a new level of investor confidence. We are excited to begin rounding out the year on such a positive note.”
Progressive Care Reports Stellar Third Quarter Results
https://ih.advfn.com/p.php?pid=nmona&article=76101390
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces financial results for the third quarter and provides updates on the Company’s strategies.
The company dispensed a total of 163,000 prescriptions during the nine months ended September 30, 2017, an increase of 2.5%. Revenues for the third quarter increased 5% to just over $5.1 million. Revenues increased 14% for the nine months ended September 30, 2017 to over $15 million. The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending PharmCo because of its high standards of patient care and attention to performance measurements and their implications.
Operating income decreased by approximately $250,000 in 2017 as compared to 2016. Third quarter operating income was negatively impacted primarily by increases in DIR fees. “DIR” stands for “direct and indirect remuneration” and was initially a term coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions that would ultimately impact the gross prescription drug costs of Medicare Part D plans that were not captured at the point of sale.
Today, DIR fees are effectively PBM clawbacks of reimbursements based on factors that vary from plan to plan. These fees lack transparency and are extremely difficult to predict and accrue. DIR fees are often applied retroactively, which has caused the cost of DIR fees to be nearly 200% higher than in the second quarter of the year. DIR fees through September 30, 2017 was over $300,000, over half of which was incurred in the third quarter. Some PBMs may reduce or return DIR Fees based on the performance of the pharmacy within their network.
Q & A Updates
New States – The Company has renewed its efforts to acquire state licenses. PharmCo has licenses pending in three new states: Utah, Arizona, and Rhode Island.
Investor Relations – First Look Equities is tasked with PR distribution. Their distribution platform is designed to increase the number of readers of the Company’s press releases and information which would ultimately have a positive impact on trading volume and shareholder value. The Company is also looking to recruit its own in-house IR team that would work to increase shareholder value.
TelePharmacy – The Company is working on a proprietary platform that would deliver technician or pharmacist consultation services direct to patients or healthcare providers through a secure digital live stream. This platform is currently being tested in Century Village of Pembroke Pines and has had an impact on company recognition, brand loyalty, and prescription processing efficiency.
Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance is quickly becoming one of South Florida's leading health services organisations
New appointments to the Board of Directors among those Oleg Firer. Oleg Firer is regarded as one of Florida most successful businessman and a Wall Street heavy hitter . He takes companies like Progressive Care (RXMD) to the next level. Check out these awesome recognitions he has received!
http://investorshub.advfn.com/boards/read_msg...=135023809
Progressive Care (RXMD) has been awarded a 5-Star Rating based on the ratings provided by various insurance carriers. Rated among the top 10% of all Pharmaceutic Benefit Networks in the NATION Progressive Care (RXMD) is right there with the big players and a major buyout target.
The ScriptPro Pharmacy Automation System is online and fully operational
http://ih.advfn.com/p.php?pid=nmona&artic...ymbol=RXMD
The Company will ship medications from its Florida facility to other states
http://www.streetinsider.com/Press+Releases/P...08843.html
Share Structure
Fully preserved OS: RXMD has basically the same OS number as compared to 2 years ago:
see ---
http://www.otcmarkets.com/stock/RXMD/profile
versus historic ---
https://web.archive.org/web/20151229173335/ht...MD/profile
Outstanding Shares a/o Jan 22, 2018 = 360,996,132 (Authorized Shares 500,000,000)
Outstanding Shares a/o Dec 09, 2015 = 352,043,045 (Authorized Shares 500,000,000)
Current market cap
of just 10 M is ~10-fold undervalued compared to hundreds of listed companies in this sector
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio* (up to 10x)...so for an estimated 25M revs in 2018 the RXMD pps fair market value, not even taking its constant market expansion into account, should be 30 cents (that is a conservative evaluation*)
14 state licenses. Expansion to 50 states
will follow within few years meaning revenue and profit multiplication!
https://ih.advfn.com/p.php?pid=nmona&article=76101390
http://finance.yahoo.com/news/progressive-car...26653.html
Now Licences pending in 3 new states : Utah, Arizona, and Rhode Island https://ih.advfn.com/p.php?pid=nmona&article=76101390
Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions
https://ih.advfn.com/p.php?pid=nmona&article=76552057
MIAMI, January 25, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to enhance the digital presence and technology solutions of the company and all subsidiaries.
Progressive Care engages Mass Ventures Corp to initiate a digital marketing campaign for both Progressive Care and PharmCo, LLC. The principle of Mass Ventures will be located on-site to provide real-time updates as needed. The campaign consists of many features including, but not limited to, website upgrades, enhanced and updated content, blog posting, social media development, press release distribution, search engine optimization, etc. Mass Ventures is also in the process of developing the Company’s e-commerce platform which will be capable of accepting all payment methods including cryptocurrencies such as Bitcoin. These measures are taken to coincide with the overall technological development of the company to improve the efficacy and exposure of the Company’s public information and virtual interaction with its shareholders and customers.
“The Mass Ventures Corp team has worked with us for over 5 years,” stated S. Parikh Mars, CEO. “We are excited to bring them on-site and begin a transformation of our online presence, as well as creating technology solutions that will modernize all areas of our enterprise. We believe that efforts in this area will make a difference in how we set ourselves apart as a company of the future. This will change how our shareholders and customers perceive and interact with us. Already, we are seeing the impact this project has had on our customer engagement and market awareness.”
“Progressive Care and PharmCo, LLC are ripe for exponential growth and success.” says Marcello Jaspan, owner and operator at MVC . “We are thrilled about the opportunity to serve such an amazing group and to work closely to create engagement and social buzz. On the technical side, we have infinite possibilities for expansion. We started with the launch of Tele-Pharmco, and we will soon have many Apps for customers and internal logistics alike. We will have goodies for everyone coming real soon, all aimed at making everyone’s lives easier and more enjoyable.”
Progressive Care Continues to Break Records with Over $20 Million in Sales
http://www.otcmarkets.com/stock/RXMD/news/Pro...50&b=y
MIAMI, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces over $20 million in net revenues on approximately 225,000 prescriptions filled in 2017.
PharmCo, LLC filled over 19,500 prescriptions during the month of December, generating approximately $1.6 million in net revenues. Prescriptions filled increased by approximately 8% over the same month last year. The company also filled over $360,000 (not included in net revenues) worth of prescriptions for 340B entities in December, generating fees to the pharmacy of over $15,000.
The company has been successful in breaking records in 2017. The company announced over $20 million in net revenues, an 11% increase over 2016. The company is expecting to achieve increased growth through 2018 as well as continued reporting of strong operational and financial performance. These all-time high sales figures indicate a positive outlook for the company into the coming year.
During the Earnings Call held on November 14, 2017, S. Parikh Mars (CEO), discussed avenues of expansion and advancement for the company during the coming year. In addition to record breaking sales, the company has been successful in its efforts to upgrade its OTCMarkets listing tier to OTCQB. The sales reported are recognized from diversified revenue streams and ongoing development of the Company’s portfolio of healthcare services. Innovation is also a factor as the company launched numerous new and exciting programs in 2017, such as its tele-pharmacy platform.
“2017 was a year of accomplishment and we are proud of all that this company has achieved,” stated S. Parikh Mars, CEO. "Reaching $20 million in sales was a challenge this year given the ever changing climate in the healthcare industry. However, we have elevated our level of service and secured our footing for continued growth and expansion in 2018. We now embark on a new set of ambitious goals for the year. Our hard work and dedication will continue to drive us as we prepare for many possible and exciting outcomes.”
S. Parikh Mars, CEO of Progressive Care Inc., Provides Progress Report and Outlook for Investors in New Audio Interview at SmallCapVoice.com
www.otcmarkets.com/stock/RXMD/news/S--Parikh-Mars--CEO-of-Progressive-Care-Inc---Provides-Progress-Report-and-Outlook-for-Investors-in-New-Audio-Interview-at-SmallCapVoice-com?id=179764&b=y
AUSTIN, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and Progressive Care Inc. (The “Company”) (OTCQB:RXMD), today announced that a new audio interview with the Company is now available. The interview can be heard at https://smallcapvoice.com/blog/1-4-18-smallca...e-inc-rxmd.
S. Parikh Mars, CEO, called in to SmallCapVoice.com to discuss the business model and markets for the company, the recent news and milestones achieved in 2017, what investors can expect from the Company in 2018, and more. In December 2017 the Company announced over $1.7 million in net revenues on nearly 21,000 prescriptions filled in November 2017. A major corporate milestone was also achieved in December as the Company was listed on a higher exchange, the OTC QB.
In the interview, Ms. Mars stated, “As experts in the pharmacy space, we market ourselves primarily to healthcare providers who are looking for pharmacies who they can recommend to their patients knowing that their patients will be well taken care of. We understand that the leading cause of ER visits and readmissions stems from a failure to adhere to a medication regiment and that affects healthcare costs and bottom lines across the healthcare system. By managing this risk, we deliver approved health outcomes to patient and lower health care costs to providers and insurance companies. This has allowed us to develop a solid reputation as a five-star pharmacy which has been a primary driver of increased sales and growth.”
For the video version of this interview, please visit https://youtu.be/oaylHtfuMgc.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-d...ewsletter/.
Progressive Care Announces Uplist to OTCQB
http://www.otcmarkets.com/stock/RXMD/news/Pro...41&b=y
MIAMI, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces OTC Markets approval for uplist to OTCQB effective December 5, 2017.
As of Tuesday, December 5 2017, Progressive Care will trade on OTCQB Venture Market for early stage and developing U.S. and international companies. The Company received approval for the change in listing tier after supplying OTC Markets with all mandatory documents and information, adding independent board members, adding a majority independent audit committee, and providing audited financial statements for 2016. Investors can still find Real-Time quotes and market information for the Company on www.otcmarkets.com (OTCQB:RXMD).
“We have been preparing for this moment since the requirements for OTCQB were announced earlier this year,” stated S. Parikh Mars, CEO. “We continue to take pride in delivering current and complete information to the public and we believe that the change in listing tier will bring our company to a fresh audience and a new level of investor confidence. We are excited to begin rounding out the year on such a positive note.”
Progressive Care Reports Stellar Third Quarter Results
https://ih.advfn.com/p.php?pid=nmona&article=76101390
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, announces financial results for the third quarter and provides updates on the Company’s strategies.
The company dispensed a total of 163,000 prescriptions during the nine months ended September 30, 2017, an increase of 2.5%. Revenues for the third quarter increased 5% to just over $5.1 million. Revenues increased 14% for the nine months ended September 30, 2017 to over $15 million. The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending PharmCo because of its high standards of patient care and attention to performance measurements and their implications.
Operating income decreased by approximately $250,000 in 2017 as compared to 2016. Third quarter operating income was negatively impacted primarily by increases in DIR fees. “DIR” stands for “direct and indirect remuneration” and was initially a term coined by the Centers for Medicare and Medicaid Services (CMS) related to the Medicare Part D benefit to address price concessions that would ultimately impact the gross prescription drug costs of Medicare Part D plans that were not captured at the point of sale.
Today, DIR fees are effectively PBM clawbacks of reimbursements based on factors that vary from plan to plan. These fees lack transparency and are extremely difficult to predict and accrue. DIR fees are often applied retroactively, which has caused the cost of DIR fees to be nearly 200% higher than in the second quarter of the year. DIR fees through September 30, 2017 was over $300,000, over half of which was incurred in the third quarter. Some PBMs may reduce or return DIR Fees based on the performance of the pharmacy within their network.
Q & A Updates
New States – The Company has renewed its efforts to acquire state licenses. PharmCo has licenses pending in three new states: Utah, Arizona, and Rhode Island.
Investor Relations – First Look Equities is tasked with PR distribution. Their distribution platform is designed to increase the number of readers of the Company’s press releases and information which would ultimately have a positive impact on trading volume and shareholder value. The Company is also looking to recruit its own in-house IR team that would work to increase shareholder value.
TelePharmacy – The Company is working on a proprietary platform that would deliver technician or pharmacist consultation services direct to patients or healthcare providers through a secure digital live stream. This platform is currently being tested in Century Village of Pembroke Pines and has had an impact on company recognition, brand loyalty, and prescription processing efficiency.
Progressive Care (RXMD) through its 100% owned subsidiaries PharmCo and Smart Medical Alliance is quickly becoming one of South Florida's leading health services organisations
New appointments to the Board of Directors among those Oleg Firer. Oleg Firer is regarded as one of Florida most successful businessman and a Wall Street heavy hitter . He takes companies like Progressive Care (RXMD) to the next level. Check out these awesome recognitions he has received!
http://investorshub.advfn.com/boards/read_msg...=135023809
Progressive Care (RXMD) has been awarded a 5-Star Rating based on the ratings provided by various insurance carriers. Rated among the top 10% of all Pharmaceutic Benefit Networks in the NATION Progressive Care (RXMD) is right there with the big players and a major buyout target.
The ScriptPro Pharmacy Automation System is online and fully operational
http://ih.advfn.com/p.php?pid=nmona&artic...ymbol=RXMD
The Company will ship medications from its Florida facility to other states
http://www.streetinsider.com/Press+Releases/P...08843.html
